Published in J Am Acad Dermatol on February 01, 2005
Guidelines of care for the management of atopic dermatitis: section 3. Management and treatment with phototherapy and systemic agents. J Am Acad Dermatol (2014) 1.32
Methotrexate in Alopecia Areata: A Report of Three Cases. Int J Trichology (2017) 0.75
p16(Ink4a) in melanocyte senescence and differentiation. J Natl Cancer Inst (2002) 2.09
Vitiligo-inducing phenols activate the unfolded protein response in melanocytes resulting in upregulation of IL6 and IL8. J Invest Dermatol (2012) 2.02
IL-17 and TNF synergistically modulate cytokine expression while suppressing melanogenesis: potential relevance to psoriasis. J Invest Dermatol (2013) 1.65
Patient perspectives on the management of atopic dermatitis. J Allergy Clin Immunol (2006) 1.55
Symmetric truncal aplasia cutis congenita following multifetal reduction of a sextuplet pregnancy. J Pediatr (2008) 1.48
Dissection of melanogenesis with small molecules identifies prohibitin as a regulator. Chem Biol (2005) 1.48
Spitz nevi: beliefs, behaviors, and experiences of pediatric dermatologists. JAMA Dermatol (2013) 1.46
Triazine-based tyrosinase inhibitors identified by chemical genetic screening. Pigment Cell Res (2005) 1.40
Pink-eyed dilution protein controls the processing of tyrosinase. Mol Biol Cell (2002) 1.29
Mebendazole induces apoptosis via Bcl-2 inactivation in chemoresistant melanoma cells. Mol Cancer Res (2008) 1.21
Developing a multidisciplinary prospective melanoma biospecimen repository to advance translational research. Am J Transl Res (2009) 1.17
Pink-eyed dilution protein modulates arsenic sensitivity and intracellular glutathione metabolism. Mol Biol Cell (2002) 1.14
The misnomer "macrocephaly-cutis marmorata telangiectatica congenita syndrome": report of 12 new cases and support for revising the name to macrocephaly-capillary malformations. Arch Dermatol (2009) 1.10
Identification of novel pigmentation modulators by chemical genetic screening. J Invest Dermatol (2007) 1.06
Pityriasis rubra pilaris, type IV. Dermatol Online J (2005) 1.03
Practical guidelines for evaluation of loose anagen hair syndrome. Arch Dermatol (2009) 1.02
Mutations in the desmoglein 4 gene underlie localized autosomal recessive hypotrichosis with monilethrix hairs and congenital scalp erosions. J Invest Dermatol (2006) 1.00
The Tyr (albino) locus of the laboratory mouse. Mamm Genome (2004) 1.00
Evidence-based recommendations for the diagnosis and treatment of pediatric acne. Pediatrics (2013) 1.00
Degradation of tyrosinase induced by phenylthiourea occurs following Golgi maturation. Pigment Cell Res (2005) 0.99
Infantile systemic hyalinosis. J Am Acad Dermatol (2004) 0.99
Porokeratotic eccrine ostial and dermal duct nevus: a report of 2 cases and review of the literature. Am J Dermatopathol (2009) 0.99
From the rarest to the most common: insights from progeroid syndromes into skin cancer and aging. J Invest Dermatol (2009) 0.99
"Pediatric blaschkitis": expanding the spectrum of childhood acquired Blaschko-linear dermatoses. Pediatr Dermatol (2007) 0.96
Ocular albinism 1 protein: trafficking and function when expressed in Saccharomyces cerevisiae. Exp Eye Res (2005) 0.96
Ehlers-Danlos syndrome type VIII: periodontitis, easy bruising, marfanoid habitus, and distinctive facies. J Am Acad Dermatol (2006) 0.95
Disulfiram induces copper-dependent stimulation of reactive oxygen species and activation of the extrinsic apoptotic pathway in melanoma. Melanoma Res (2010) 0.94
Planning for a brighter future: a review of sun protection and barriers to behavioral change in children and adolescents. Dermatol Online J (2008) 0.94
Celastrol synergistically enhances temozolomide cytotoxicity in melanoma cells. Mol Cancer Res (2009) 0.94
Identification of quinolines that inhibit melanogenesis by altering tyrosinase family trafficking. Mol Pharmacol (2008) 0.93
The Dermatology Foundation: partnerships and programs focused on the future. J Invest Dermatol (2013) 0.92
Oxidative stress activates FUS1 and RLM1 transcription in the yeast Saccharomyces cerevisiae in an oxidant-dependent Manner. Mol Biol Cell (2004) 0.92
Extensive Riga-Fede disease of the lip and tongue. J Am Acad Dermatol (2002) 0.91
Inhibition of mitochondrial protein translation sensitizes melanoma cells to arsenic trioxide cytotoxicity via a reactive oxygen species dependent mechanism. Cancer Chemother Pharmacol (2008) 0.91
Mucosal dominant pemphigus vulgaris with anti-desmoplakin autoantibodies. J Am Acad Dermatol (2004) 0.90
Experience with molluscum contagiosum and associated inflammatory reactions in a pediatric dermatology practice: the bump that rashes. Arch Dermatol (2012) 0.90
The ocular albinism type 1 gene product, OA1, spans intracellular membranes 7 times. Exp Eye Res (2007) 0.89
Antifolate activity of pyrimethamine enhances temozolomide-induced cytotoxicity in melanoma cells. Mol Cancer Res (2009) 0.88
Rab27b association with melanosomes: dominant negative mutants disrupt melanosomal movement. J Invest Dermatol (2002) 0.88
Fluvastatin enhances sorafenib cytotoxicity in melanoma cells via modulation of AKT and JNK signaling pathways. Anticancer Res (2011) 0.88
Mucocutaneous neuromas: an underrecognized manifestation of PTEN hamartoma-tumor syndrome. Arch Dermatol (2006) 0.87
XIAP downregulation accompanies mebendazole growth inhibition in melanoma xenografts. Anticancer Drugs (2013) 0.86
Oral retinoid therapy for dermatologic conditions in children and adolescents. J Am Acad Dermatol (2003) 0.86
Heterologous expression of tyrosinase recapitulates the misprocessing and mistrafficking in oculocutaneous albinism type 2: effects of altering intracellular pH and pink-eyed dilution gene expression. Exp Eye Res (2005) 0.85
Accumulation of tyrosinase in the endolysosomal compartment is induced by U18666A. Pigment Cell Res (2003) 0.85
Pigmented plexiform neurofibroma: Distinction from a large congenital melanocytic nevus. J Am Acad Dermatol (2007) 0.84
Abortive segmental perineal hemangioma. Dermatol Online J (2011) 0.84
The unfolded protein response in melanocytes: activation in response to chemical stressors of the endoplasmic reticulum and tyrosinase misfolding. Pigment Cell Melanoma Res (2010) 0.84
Identification of the F1F0 mitochondrial ATPase as a target for modulating skin pigmentation by screening a tagged triazine library in zebrafish. Mol Biosyst (2005) 0.84
Sulforaphane synergistically enhances the cytotoxicity of arsenic trioxide in multiple myeloma cells via stress-mediated pathways. Oncol Rep (2012) 0.83
Radiation therapy for high-risk squamous cell carcinomas in patients with xeroderma pigmentosum: report of two cases and review of the literature. Dermatology (2011) 0.82
Correction of defective early tyrosinase processing by bafilomycin A1 and monensin in pink-eyed dilution melanocytes. Pigment Cell Res (2004) 0.81
Enhancement of arsenic trioxide cytotoxicity by dietary isothiocyanates in human leukemic cells via a reactive oxygen species-dependent mechanism. Leuk Res (2009) 0.81
Cole Disease Results from Mutations in ENPP1. Am J Hum Genet (2013) 0.80
25-hydroxycholesterol acts in the Golgi compartment to induce degradation of tyrosinase. Pigment Cell Res (2004) 0.80
Albendazole sensitizes cancer cells to ionizing radiation. Radiat Oncol (2011) 0.79
Identification of compounds that bind mitochondrial F1F0 ATPase by screening a triazine library for correction of albinism. Chem Biol (2004) 0.78
Cole disease: guttate hypopigmentation and punctate palmoplantar keratoderma. Arch Dermatol (2009) 0.77
Chemical genetic screening identifies tricyclic compounds that decrease cellular melanin content. J Invest Dermatol (2007) 0.77
Lichen planopilaris noted during etanercept therapy in a child with severe psoriasis. Pediatr Dermatol (2009) 0.77
Efficacy and safety of oral retinoids in psoriasis. Expert Opin Drug Saf (2005) 0.77
Juvenile myelomonocytic leukemia presenting with features of hemophagocytic lymphohistiocytosis in association with neurofibromatosis and juvenile xanthogranulomas. J Pediatr Hematol Oncol (2004) 0.76
Patient-reported outcomes in pediatric patients with psoriasis undergoing etanercept treatment: 12-week results from a phase III randomized controlled trial. J Am Acad Dermatol (2010) 0.76
Congenital Spitz nevus clinically mimicking melanoma. J Am Acad Dermatol (2002) 0.76
Loss of Oca2 disrupts the unfolded protein response and increases resistance to endoplasmic reticulum stress in melanocytes. Pigment Cell Melanoma Res (2013) 0.76
X-linked recessive ichthyosis. Dermatol Online J (2005) 0.76
The physician-scientist. J Invest Dermatol (2006) 0.76
Informed reasoning: repositioning of nitisinone to treat oculocutaneous albinism. J Clin Invest (2011) 0.75
Identification of agents that promote endoplasmic reticulum stress using an assay that monitors luciferase secretion. J Biomol Screen (2013) 0.75
Melanocytic proliferations in the setting of vulvar lichen sclerosus: diagnostic considerations. Pediatr Dermatol (2005) 0.75
Engineering a new mouse model for vitiligo. J Invest Dermatol (2012) 0.75
Morphea, diabetes mellitus type I, and celiac disease: case report and review of the literature. Pediatr Dermatol (2010) 0.75
Phacomatosis pigmentokeratotica associated with hemihypertrophy and a rhabdomyosarcoma of the abdominal wall. J Am Acad Dermatol (2006) 0.75
Dermatologists' attitudes, prescription, and counseling patterns for isotretinoin: a questionnaire-based study. J Drugs Dermatol (2015) 0.75
Eccrine angiomatous hamartoma. Dermatol Online J (2006) 0.75
Cutaneous features of Crouzon syndrome with acanthosis nigricans. JAMA Dermatol (2013) 0.75
Juvenile amyopathic dermatomyositis. Dermatol Online J (2005) 0.75
Infantile granular parakeratosis: recognition of two clinical patterns. J Am Acad Dermatol (2004) 0.75